These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6542050)

  • 1. Adriamycin and cis-diamminedichloroplatinum in the treatment of metastatic endometrial adenocarcinoma.
    Seltzer V; Vogl SE; Kaplan BH
    Gynecol Oncol; 1984 Nov; 19(3):308-13. PubMed ID: 6542050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of cisplatin, adriamycin, and etoposide for metastatic endometrial adenocarcinoma.
    Piver MS; Fanning J; Baker TR
    Am J Clin Oncol; 1991 Jun; 14(3):200-2. PubMed ID: 2031506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
    Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group Study.
    Alberts DS; Mason NL; O'Toole RV; Hilgers RD; Rivkin SE; Boutselis JG; Pugh RP; Vaitkevicius VK; Green JB; Oishi N
    Gynecol Oncol; 1987 Feb; 26(2):193-201. PubMed ID: 3542743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of a combination chemotherapy with ifosfamide, adriamycin and cisplatin for endometrial carcinoma.
    Nishida T; Nagasue N; Kishi N; Imaishi K; Tateno N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1883-8. PubMed ID: 3209914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
    Turbow MM; Ballon SC; Sikic BI; Koretz MM
    Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced endometrial carcinoma with cisplatin, cyclophosphamide and doxorubicin.
    Deppe G; Lin Liu T
    Acta Obstet Gynecol Scand; 1985; 64(1):83-4. PubMed ID: 4038840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients.
    Pasmantier MW; Coleman M; Silver RT; Mamaril AP; Quiguyan CC; Galindo A
    Cancer Treat Rep; 1985 May; 69(5):539-42. PubMed ID: 4039980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of recurrent endometrial cancer (clear cell adenocarcinoma) remarkably responsive to combination chemotherapy containing cisplatin].
    Kitayama S; Iwahashi M; Iwahashi M; Yamoto M; Nakano R
    Gan To Kagaku Ryoho; 1989 May; 16(5):2099-101. PubMed ID: 2730095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine papillary serous carcinoma. Complete response to combination chemotherapy.
    Fitzgerald D; Rosenthal S
    Cancer; 1985 Sep; 56(5):1023-4. PubMed ID: 4040419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced or recurrent adenocarcinoma of the endometrium with doxorubicin and cyclophosphamide.
    Campora E; Vidali A; Mammoliti S; Ragni N; Conte PF
    Eur J Gynaecol Oncol; 1990; 11(3):181-3. PubMed ID: 2209636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix.
    Kavanagh JJ; Gershenson D; Copeland L; Roberts WS
    J Clin Oncol; 1987 Oct; 5(10):1621-3. PubMed ID: 3655859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
    Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
    Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T; Wakabayashi Y; Kim T; Ishida A; Arai Y; Konishi T; Pak K; Takeuchi H; Tomoyoshi T; Watanabe J
    Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
    Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
    Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma.
    Lupera H; Droz JP; Piot G; Lapleige P; Fargeot P; Theodore C
    Oncology; 1989; 46(6):372-4. PubMed ID: 2587004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.